These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11454941)

  • 21. Effects of environmental enrichment on behavior and dopamine transporter function in medial prefrontal cortex in adult rats prenatally treated with cocaine.
    Neugebauer NM; Cunningham ST; Zhu J; Bryant RI; Middleton LS; Dwoskin LP
    Brain Res Dev Brain Res; 2004 Nov; 153(2):213-23. PubMed ID: 15527889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
    Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2002 Jun; 965():136-56. PubMed ID: 12105091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine.
    Thomas DM; Kuhn DM
    J Neurochem; 2005 Feb; 92(4):790-7. PubMed ID: 15686480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice.
    D'Astous M; Mickley KR; Dluzen DE; Di Paolo T
    Neuroendocrinology; 2005; 82(2):111-20. PubMed ID: 16446547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B; Dluzen DE
    Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: effects of age and sex.
    Glatt SJ; Trksak GH; Cohen OS; Simeone BP; Jackson D
    Synapse; 2004 Aug; 53(2):74-89. PubMed ID: 15170820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits.
    Jeng W; Wong AW; Ting-A-Kee R; Wells PG
    Free Radic Biol Med; 2005 Aug; 39(3):317-26. PubMed ID: 15993330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.
    Truong JG; Wilkins DG; Baudys J; Crouch DJ; Johnson-Davis KL; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1087-92. PubMed ID: 15901804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomifensine alters sex differences in striatal dopaminergic function.
    Poth LS; O'Connell BP; McDermott JL; Dluzen DE
    Synapse; 2012 Aug; 66(8):686-93. PubMed ID: 22389194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
    Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal exposure to diphenhydramine during the fetal period in rats: effects on physical and neurobehavioral development and on neurochemical parameters.
    Moraes AP; Schwarz A; Spinosa HS; Florio JC; Bernardi MM
    Neurotoxicol Teratol; 2004; 26(5):681-92. PubMed ID: 15315817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
    Theodore S; Cass WA; Maragos WF
    Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2004 Oct; 1025():205-20. PubMed ID: 15542719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
    Anderson KL; Itzhak Y
    Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats.
    Schröder N; O'Dell SJ; Marshall JF
    Synapse; 2003 Aug; 49(2):89-96. PubMed ID: 12740864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC; Dluzen DE
    Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.